Pharmaceutical Manufacturing & Packaging Market Reports

Find the information you need on pharmaceutical manufacturing and packaging. The Kalorama Information collection of research reports provides insights into product trends, analyses, opportunities, projections, and marketing strategies. Specifics on market share, size, and growth in US and global are also featured. You’ll find the latest information regarding manufacturing outsourcing trends; transgenic animals and plants in pharma manufacturing, and more.

Title	Published	Price
Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE) At present the Middle East region constitutes as small percent of global pharmaceutical sales. However, ever-increasing populations and governmental healthcare reforms are likely to increase demand. These markets will be essential for pharmaceuticals companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for  |  more... Search inside this report	Nov 1, 2008	$3,300.00
Key Healthcare Opportunities for Technology Companies (Wireless in Healthcare 2008-12, High-Tech Patient Monitoring Systems, RFID in Pharma Manufacturing, US EMR Markets, RFID in Healthcare, Electronic Components for Medical Device Markets) According to Kalorama's experts, there is over a 40 billion dollar market for technology companies who can assist the healthcare industry meet its key challenges. This Kalorama Information Market Research Bundle, a combination of 7 Kalorama Information Market research reports - over 1200 pages of material. , presents those opportunities,  |  more... Buy by the section	Oct 1, 2008	$7,995.00
Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations ) Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China’s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing regions and petro-rich  |  more... Search inside this report	Jul 1, 2008	$3,500.00
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition 2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent  |  more...	May 1, 2008	$3,500.00
The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies Lagging FDA approvals led to a brief absence of Rx to OTC switches in the pharmaceutical marketplace, but 2006 and 2007 saw a number of switches, and Kalorama Information believes this product management tactic will continue to be aggressively utilized as companies seek ways to extend revenue life.  |  more...	Apr 1, 2008	$1,995.00
RFID in Pharmaceutical Manufacturing: Cost Saving Strategies for Pharmaceutical Companies and Opportunities for Technology Companies Pharmaceutical manufacturers are utilizing new RIFD technologies to deal with multiple challenges they face in the manufacturing process. This Kalorama Information report discussions the solutions available, and covers the opportunities available to technology companies to provide services to this sector. Full coverage of the market for RFID technologies  |  more...	Mar 1, 2008	$1,995.00
Pharmaceutical Excipients for Oral Formulations, 2nd. Edition Pharmaceutical excipients are substances, other than the pharmacologically active drug or prodrug, which are included in the manufacturing process or are contained in the finished pharmaceutical product dosage form. Excipients provide enhanced functionality to the pharmaceuticals, aid the innovations in the drug development and help improve patent life as well.  |  more... Search inside this report	Feb 1, 2008	$3,995.00
Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 2nd Edition This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. The report contains vital market statistics on three main segments of pharmaceutical contract  |  more... Buy by the section | Search inside this report	Sep 1, 2006	$3,900.00
Transgenic Animals and Plants in Pharmaceutical Research and Manufacturing With the mapping of the human genome and the concomitant explosion of proteomics, a steady stream of biopharmaceuticals have been launched—recombinant therapeutic proteins, monoclonal antibody-based products used for therapeutic or in vivo diagnostic purposes, and nucleic acid-based products. As the rate of regulatory approval for biopharmaceuticals increases, the  |  more... Buy by the section | Search inside this report	Jan 1, 2006	$2,995.00
Pharmaceutical Outsourcing Opportunities Post Launch: Contract Manufacturing, and Sales and Marketing After decades of sustained growth and profitability, the pharmaceutical industry has been positioned as one of the few recession proof industries based on its performance through multiple economical cycles. In recent years, there have been visible strains in the pharmaceutical business. With a downturn in fortunes, many pharmaceutical companies  |  more... Buy by the section | Search inside this report	Jul 1, 2004	$3,500.00
The Pharmaceutical Contract Manufacturing Marketplace Outsourcing pharmaceutical production is not new, and the benefits to big pharma companies are well documented. However, rapid changes in the kinds of drugs, the delivery technologies they will require, the expertise to scale-up new biopharmaceuticals, and even changes in capacity demand are all on the horizon for the contract  |  more... Buy by the section | Search inside this report	Jan 1, 2002	$2,625.00
The Market for Drug Packaging Many factors continue to drive growth in the drug packaging market, particularly unit dosing, Rx to over-the-counter switches, and generic substitution. This report from Kalorama Information analyzes the competitive environment associated with packaging a process which has grown more elaborate, sophisticated, and scientific. Eight segments are explored: blister packages, blow-molded  |  more... Search inside this report	Jan 1, 1998	$2,437.50
Title	Published	Price